Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
First Edition BOGP (0)
Norvège (1)
Advocacy (policy advocacy, lobbying)
Patient Advocacy Organization (4)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Continuity and sustainability
Clinical study phase II